Small Cell Lung Cancer Clinical Trials in Lexington, Kentucky

3 studies are recruiting for small cell lung cancer in Lexington, Kentucky right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer

    Small cell lung cancer (SCLC) is characterized by aggressive and rapid growth and a tendency to develop early spread to distant sites including mediastinal lymph nodes, liver, bones, adrenal glands, and brain. The purpose of this study is to assess safety, dose, change in disease activity of ABBV-7…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Baptist Health Lexington /ID# 277729, Lexington, Kentucky
    Locations
    67 in total
    Run by
    AbbVie

    See if you can join NCT07155174 on ClinicalTrials.gov

  2. A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

    This study is designed to compare the efficacy and safety of I-DXd with treatment of physician's choice in participants with relapsed small cell lung cancer (SCLC).

    Stage
    Phase 3
    Ages
    18 and older
    Site
    Baptist Health Lexington, Lexington, Kentucky
    Locations
    229 in total
    Run by
    Daiichi Sankyo

    See if you can join NCT06203210 on ClinicalTrials.gov

  3. A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung Cancer

    This is a multi-center, open-label, Phase 1 clinical study of ZG006 in the US for the treatment of subjects with small cell lung cancer who have failed or are intolerant to available standard treatment. During the dose escalation stage, a standard "3+3" design will be used to assess the MTD/ recomm…

    Stage
    Phase 1
    Ages
    18 to 75
    Site
    Zelgen Site 103, Lexington, Kentucky
    Locations
    6 in total
    Run by
    Suzhou Zelgen Biopharmaceuticals Co.,Ltd

    See if you can join NCT06592638 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.